Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Bio-Thera Solutions
Related studies linked through entity extraction aliases.
A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants
- Status
- RECRUITING
- Phase
- PHASE1
A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 in the Treatment of Locally Advanced or Metastatic Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
A Study to Evaluate PK, Efficacy, and Safety of BAT3306 Plus Chemo and Compare With Keytruda®(EU/US) in Participants With IV nqNSCLC
- Status
- TERMINATED
- Phase
- PHASE3
Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Patients
- Status
- RECRUITING
- Phase
- PHASE1
BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Compare the Pharmacokinetics and Safety of BAT3306 Injection Versus KEYTRUDA® Administered in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Evaluate the Safety, Tolerability of BAT6026
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Randomized, Double-blind, Single-dose, Two-arm Parallel Study to Compare the Pharmacokinetics and Safety of BAT1806 Prefilled Subcutaneous Injection With RoActemra® in Healthy Chinese Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Comparative Pharmacokinetic Study to Evaluate Different Manufacturing Batches of BAT1706 Injection
- Status
- UNKNOWN
- Phase
- PHASE1
Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Study of Stage IV Psoriasis in Children With Geleli
- Status
- COMPLETED
- Phase
- N/A
BAT7104 Injection in Patients With Advanced Malignant Tumors.
- Status
- COMPLETED
- Phase
- PHASE1
Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection
- Status
- RECRUITING
- Phase
- PHASE1